EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of PLK1-PBD Inhibitors from the Library of Marine Natural Products: 3D QSAR Pharmacophore, ADMET, Scaffold Hopping, Molecular Docking, and Molecular Dynamics Study

Nan Zhou, Chuangze Zheng, Huiting Tan, Lianxiang Luo iD

Marine Drugs · 10.02.2024 · 22 (2) · 83

DOI: 10.3390/md22020083 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Marine Drugs, online erschienen am 10.02.2024. Verfasst von Nan Zhou und 3 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical College, Guangdong Medical University, Zhanjiang 524023, China. Hauptthemen laut MEDLINE: Biological Products, Ammonium Compounds. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Science and technology program of Guangdong Province, The Key Discipline Construction Project of Guangdong Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PLK1 is found to be highly expressed in various types of cancers, but the development of inhibitors for it has been slow. Most inhibitors are still in clinical stages, and many lack the necessary selectivity and anti-tumor effects. This study aimed to create new inhibitors for the PLK1-PBD by focusing on the PBD binding domain, which has the potential for greater selectivity. A 3D QSAR model was developed using a dataset of 112 compounds to evaluate 500 molecules. ADMET prediction was then used to select three molecules with strong drug-like characteristics. Scaffold hopping was employed to reconstruct 98 new compounds with improved drug-like properties and increased activity. Molecular docking was used to compare the efficient compound abbapolin, confirming the high-activity status of [(14S)-14-hydroxy-14-(pyridin-2-yl)tetradecyl]ammonium,[(14S)-15-(2-furyl)-14-hydroxypentadecyl]ammonium and [(14S)-14-hydroxy-14-phenyltetradecyl]ammonium. Molecular dynamics simulations and MMPBSA were conducted to evaluate the stability of the compounds in the presence of proteins. An in-depth analysis of [(14S)-15-(2-furyl)-14-hydroxypentadecyl]ammonium and [(14S)-14-hydroxy-14-phenyltetradecyl]ammonium identified them as potential candidates for PLK1 inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biological ProductsAmmonium CompoundsMolecular Docking SimulationMolecular Dynamics SimulationQuantitative Structure-Activity RelationshipPharmacophore

Stichwörter der Autor:innen

3D QSAR pharmacophorePLK1-PBDmarine natural compoundsmolecular dockingmolecular dynamicsscaffold hoppingvirtual screening

Substanzen

Biological ProductsAmmonium Compounds

Autor:innen und Institutionen

  • The First Clinical College, Guangdong Medical University, Zhanjiang 524023, China.
  • The Marine Biomedical Research Institute, School of Ocean and Tropical Medicine, Guangdong Medical University, Zhanjiang 524023, China.
  • The Marine Biomedical Research Institute of Guangdong Zhanjiang, Zhanjiang 524023, China.

ORCID-Profile: Lianxiang Luo

Förderung

  • The Science and technology program of Guangdong Province
  • The Key Discipline Construction Project of Guangdong Medical University

Zitieren

APA

Zhou, N., Zheng, C., Tan, H., & Luo, L. (2024). Identification of PLK1-PBD Inhibitors from the Library of Marine Natural Products: 3D QSAR Pharmacophore, ADMET, Scaffold Hopping, Molecular Docking, and Molecular Dynamics Study. Marine Drugs, 22(2), 83. https://doi.org/10.3390/md22020083

Vancouver

Zhou N, Zheng C, Tan H, Luo L. Identification of PLK1-PBD Inhibitors from the Library of Marine Natural Products: 3D QSAR Pharmacophore, ADMET, Scaffold Hopping, Molecular Docking, and Molecular Dynamics Study. Marine Drugs. 2024;22(2):83. doi:10.3390/md22020083

BibTeX
@article{Zhou2024,
  author = {Zhou, Nan and Zheng, Chuangze and Tan, Huiting and Luo, Lianxiang},
  title = {Identification of PLK1-PBD Inhibitors from the Library of Marine Natural Products: 3D QSAR Pharmacophore, ADMET, Scaffold Hopping, Molecular Docking, and Molecular Dynamics Study},
  journal = {Marine Drugs},
  year = {2024},
  volume = {22},
  number = {2},
  pages = {83},
  doi = {10.3390/md22020083}
}
Kostenlos starten →